Bladder Cancer is Associated with Low Plasma 25-hydroxyvitamin D Concentrations in Tunisian Population

References

• Parkin DM: The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl 218, 12–20, 2008.
   PubMedGoogle Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al.: GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr
   Google Scholar
• Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, et al.: Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63, 234–241, 2013. doi: 10.1016/j.eururo.2012.07.033
   PubMed Web of Science ®Google Scholar
• Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Willett WC, et al.: Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 152, 1145–1153, 2000.
   PubMed Web of Science ®Google Scholar
• Jacobs EJ, Henion AK, Briggs PJ, Connell CJ, McCullough ML, et al.: Vitamin C and vitamin E supplement use and bladder cancer mortality in a large cohort of US men and women. Am J Epidemiol 156, 1002–1010, 2002.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, et al.: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98, 451–459, 2006.
   PubMed Web of Science ®Google Scholar
• Brinkman MT, Karagas MR, Zens MS, Schned A, Reulen RC, et al.: Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study. Cancer Causes Control 21, 609–619, 2010. doi:10.1007/s10552-009-9490-0
   PubMed Web of Science ®Google Scholar
• Brinkman MT, Buntinx F, Kellen E, Dagnelie PC, Van Dongen MC, et al.: Dietary intake of micronutrients and the risk of developing bladder cancer: results from the Belgian case-control study on bladder cancer risk. Cancer Causes Control 22, 469–478, 2011. doi:10.1007/s10552-010-9718-z
   PubMed Web of Science ®Google Scholar
• Mocellin S: Vitamin D and cancer: deciphering the truth. Biochim Biophys Acta 1816, 172–178, 2011. doi:10.1016/j.bbcan.2011.07.001
   PubMed Web of Science ®Google Scholar
• Brunner RL, Wactawski-Wende J, Caan BJ, Cochrane BB, Chlebowski RT, Gass ML, et al.: The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer 63, 827–841, 2011. doi: 10.1080/01635581.2011.594208
   PubMed Web of Science ®Google Scholar
• Yin L, Ordóñez-Mena JM, Chen T, Schöttker B, Arndt V, et al.: Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Prev Med 57, 753–764, 2013. doi:10.1016/j.ypmed.2013.08.026
   PubMed Web of Science ®Google Scholar
• Ordóñez Mena JM and Brenner H: Vitamin D and cancer: an overview on epidemiological studies. Adv Exp Med Biol 810, 17–32, 2014.
   PubMedGoogle Scholar
• Mondul AM, Weinstein SJ, Männistö S, Snyder K, Horst RL, et al.: Serum vitamin D and risk of bladder cancer. Cancer Res 70, 9218–9223, 2010. doi:10.1158/0008-5472.CAN-10-0985
   PubMed Web of Science ®Google Scholar
• Mondul AM, Weinstein SJ, Horst RL, Purdue M, Albanes D. Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial. Cancer Epidemiol Biomarkers Prev 21, 1222–1225, 2012. doi:10.1158/1055-9965.EPI-12-0439
   PubMed Web of Science ®Google Scholar
• Amaral AF, Méndez-Pertuz M, Muñoz A, Silverman DT, Allory Y, et al.: Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. J Natl Cancer Inst 104, 1897–1904, 2012. doi:10.1093/jnci/djs444.
   PubMedGoogle Scholar
• Afzal S, Bojesen SE, and Nordestgaard BG: Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem 59, 771–780, 2013. doi: 10.1373/clinchem.2012.201939
   PubMed Web of Science ®Google Scholar
• Kefi R, Hsouna S, Ben Halim N, Lasram K, Romdhane L, et al.: Phylogeny and genetic structure of Tunisians and their position within Mediterranean populations. Mitochondrial DNA. 2014 Feb 3. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Greene FL, Page DL, Flemming ID, Fritz A, Balch CM, et al.: American Joint Committee on Cancer Staging Manual. New York: Springer-Verlag, 2002.
   Google Scholar
• Institute of Medicine: Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press, 2011.
   Google Scholar
• Pommergaard HC, Burcharth J, Rosenberg J, and Raskov H: Oral chemoprevention with acetyl salicylic Acid, vitamin D and calcium reduces the risk of tobacco carcinogen-induced bladder tumors in mice. Cancer Invest 31, 490–493, 2013. doi:10.3109/07357907.2013.820316
   PubMed Web of Science ®Google Scholar
• Konety BR, Lavelle JP, Pirtskalaishvili G, Dhir R, Meyers SA, et al.: Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. J Urol 165, 253–258, 2001.
   PubMed Web of Science ®Google Scholar
• Hsu JW, Yin PN, Wood R, Messing J, Messing E, et al.: 1-alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer. Oncotarget 4, 2397–2406, 2013.
   PubMed Web of Science ®Google Scholar
• Ma Y, Yu WD, Trump DL, and Johnson CS: 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer 116, 3294–3303, 2010. doi:10.1002/cncr.25059
   PubMed Web of Science ®Google Scholar
• Liao Y, Huang JL, Qiu MX, and Ma ZW: Impact of serum vitamin D level on risk of bladder cancer: a systemic review and meta-analysis. Tumour Biol 36, 1567–1572, 2015.
   PubMed Web of Science ®Google Scholar
• McCullough ML, and Mayo TL: Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 29, 111–132, 2009. doi:10.1146/annurev-nutr-080508-141248
   PubMed Web of Science ®Google Scholar
• Meddeb N, Sahli H, Chahed M, Abdelmoula J, Feki M, et al.: Vitamin D deficiency in Tunisia. Osteoporos Int 16, 180–183, 2005.
   PubMed Web of Science ®Google Scholar
• Bassil D, Rahme M, Hoteit M, and Fuleihan Gel-H: Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol 5, 274–298, 2013. doi:10.4161/derm.25111
   PubMedGoogle Scholar
• Chen F, Li Q, Yu Y, Yang W, Shi F, et al.: Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis. Sci Rep 5, 9599, 2015. doi:10.1038/srep09599
   PubMed Web of Science ®Google Scholar